Ixekizumab
Written By Dr. Swati Mishra
Reviewed By Dr. Rajeev SharmaLast updated 25 Nov 2025 | 09:34 AM (UTC)
Ixekizumab Uses
Ixekizumab is used in the treatment of multiple sclerosis (MS), psoriatic arthritis and psoriasis.
How Ixekizumab works
Ixekizumab works by blocking the action of a certain natural substance (Interleukin 17A) in the body that causes the symptoms of psoriasis.
Common side effects of Ixekizumab
Injection site reactions (pain, swelling, redness), Upper respiratory tract infection, Nausea, Fungal infection of skin
Want to Know More
Read Our Editorial PolicyMedicine brands for Ixekizumab
Expert advice for Ixekizumab
- Inform your doctor if you are allergic to Ixekizumab, any other medications, or any of the ingredients in Ixekizumab.
- Ixekizumab is a medicine that affects your immune system. It may lower the ability of your immune system to fight infections and may increase your risk of infections, which can sometimes become serious.
- You must inform your doctor if you have tuberculosis or have been in close contact with someone with tuberculosis.
- Inform your doctor if you have an infection or have symptoms of an infection such as fever, cough, diarrhea, weight loss, etc.
Frequently asked questions for Ixekizumab
Ixekizumab is a monoclonal antibody used to treat certain inflammatory conditions. It is commonly prescribed for treatment of moderate to severe psoriatic arthritis. By targeting and inhibiting interleukin-17A (IL-17A), a cytokine involved in inflammatory and immune responses, Ixekizumab helps reduce the symptoms of these conditions.
Ixekizumab is administered via subcutaneous injection. It comes in prefilled syringes or autoinjectors, and the injections are typically given once every two to four weeks, depending on the specific condition and treatment plan prescribed by the doctor.
Ixekizumab is not recommended for individuals with a history of severe allergic reactions to the medication or its components. Additionally, patients with active infections or tuberculosis should not use Ixekizumab. A thorough medical history and evaluation by a doctor is necessary to determine if Ixekizumab is a safe option.
The safety of Ixekizumab during pregnancy and breastfeeding has not been well established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their doctor.
The time it takes for Ixekizumab to show improvement in symptoms can vary among individuals. Some patients may notice a reduction in symptoms within the first few weeks of treatment, while for others, it may take longer. Continuous use as prescribed is important for achieving the best results.
Ixekizumab should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). It should not be frozen. If necessary, Ixekizumab can be kept at room temperature (up to 30°C or 86°F) for up to five days, but it must be used within this timeframe or discarded. The medication should be kept in its original packaging to protect it from light and kept out of reach of children and pets.